Humacyte, Inc. (HUMA)
Nasdaq: HUMA · Biological Products, (No Diagnostic Substances) · Durham, NC · filing with the SEC since 2020
Who owns Humacyte, Inc.
As filed with the SECHolders of 5% or more
1
Fresenius Medical Care AG holds 9.5% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13D/A filed Jan 9, 2026 says.
Directors and officers
15
report now, of 29 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Fresenius Medical Care AG
SCHEDULE 13D/A · filed Jan 9, 2026 · Common Stock, par value $0.0001 per share · 9.9% in Oct 16, 2025
Fresenius Medical Care Holdings, Inc.
SCHEDULE 13D/A · filed Aug 18, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 6.8% in Jul 13, 2026
Davidson Kempner Capital Management LP
SCHEDULE 13G · filed Jun 22, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 28, 2026 · Common Stock · reported falling below 5%
What HUMA reports owning in othersstakes of 5% or more, and other ties
Humacyte, Inc. reports no stake in another company in the record.
Insider tradesForm 4
2sales
5purchases
2sales on a scheduled plan
2people selling
$100,000sold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Oct 7, 2025 to Oct 7, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 7, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 32 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Jones Keith Anthony | director | 0 | $0 | 0 | 3 | $0 |
| Constantino Michael T. | director | 0 | $0 | 0 | 1 | $0 |
| Sebelius Kathleen | director | 0 | $0 | 0 | 1 | $0 |
| Sander Dale A. | CFO and Chief Corp. Dev. Off | 1 | $0 | 1 | 0 | $0 |
| Parikh Shamik J | Chief Medical Officer | 1 | $0 | 1 | 0 | $0 |